Regulation of Cell Growth by Recombinant Oncostatin M

References

• Boyd F. T., Massague J. Transforming growth factor-β inhibition of epithelial cell proliferation linked to the expression of a 53-kda membrane receptor. J. Biol. Chem. 1989; 264: 2272–2278
   PubMed Web of Science ®Google Scholar
• Brown T. J., Lioubin M. N., Marquardt H. Purification and characterization of cytostatic lymphokines produced by activated human T lymphocytes: Synergistic antiproliferative activity of transforming growth factor β-1, interferon- γ, and oncostatin M for human melanoma cells. J. Immunol. 1987; 139: 2977–2983
   PubMed Web of Science ®Google Scholar
• Centrella M., McCarthy T. L., Canalis E. Transforming growth factor-β is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cells. J. Biol. Chem. 1987; 262: 2869–2874
   PubMed Web of Science ®Google Scholar
• Chakrabarty S., Jan Y., Brattain M., Tobon A., Varani J. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-β. Cancer Res. 1989; 49: 2112–2117
   PubMed Web of Science ®Google Scholar
• Chen L., Mory Y., Zilberstein A., Revel M. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon. Proc. Natl. Acad. Sci. USA 1988; 85: 8037–8041
   PubMed Web of Science ®Google Scholar
• Clark A. F. Potential role of fibronectin in cutaneous wound repair. Arch. Dermatol. 1988; 124: 201–206
   PubMedGoogle Scholar
• Creasey A. A., Yamanoto R., Vitt C. R. A high molecular weight component of the human tumor necrosis factor receptor is associated with cytotoxicity. Proc. Natl. Acad. Sci. USA 1987; 84: 3293–3297
   PubMed Web of Science ®Google Scholar
• Dedhar S., Gaboury L., Galloway P., Eaves C. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of non-hemopoietic origin. Proc. Natl. Acad. Sci. USA 1988; 85: 9253–9257
   PubMed Web of Science ®Google Scholar
• Deuel T. F. Polypeptide growth factors: roles in normal and abnormal cell growth. Annu. Rev. Cell Biol. 1987; 3: 443–492
   PubMedGoogle Scholar
• Fryling C. M., Iwata K. K., Johnson P. A., Knott W. B., Todaro G. J. Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line. Cancer Res. 1985; 45: 2695–2699
   PubMed Web of Science ®Google Scholar
• Gaffney E. V., Tsai S. C. Lymphocyte-activating and growth-inhibitory activities for several sources of native and recombinant interleukin 1. Cancer Res. 1986; 46: 3834–3837
   PubMed Web of Science ®Google Scholar
• Gowen M., Mundy G. R. Actions of recombinant interleukin 1, interleukin 2, and interferon-y on bone resorption in vitro. J. Immunol. 1986; 136: 2478–2482
   PubMed Web of Science ®Google Scholar
• Hynes R. O. Integrins: a family of cell surface receptors. Cell 1987; 48: 549–554
   PubMed Web of Science ®Google Scholar
• Iwata K. K., Fryling C. M., Knott W. B., Todaro G. J. Isolation of tumor cell growth-inhibiting factors from a human rhabdosarcoma cell line. Cancer Res. 1985; 45: 2689–2694
   PubMed Web of Science ®Google Scholar
• Kamata N., Chida K., Rikimaru K., Horikoshi M., Enomoto S., Kuroki T. Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture. Cancer Res. 1986; 46: 1648–1653
   PubMed Web of Science ®Google Scholar
• Kohase M., Henricksen-DeStefano D., May L. T., Vilcek J., Sehgal P. B. Induction of interferon by tumor necrosis factor: A homeostatic mechanism in the control of cell proliferation. Cell 1986; 45: 659–666
   PubMed Web of Science ®Google Scholar
• Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Leof E. B., Proper J. A., Goustin A. S., Shipley G. D., DiCorleto P. E., Moses H. L. Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor β: A proposed model for indirect mitogenesis involving autocrine activity. Proc. Natl. Acad. Sci. USA 1986; 83: 2453–2457
   PubMed Web of Science ®Google Scholar
• Lever J. E. Regulation of dome formation in kidney epithelial cell cultures. Ann NY Acad. Sci. 1981; 372: 371–381
   PubMedGoogle Scholar
• Linsley P. S., Hanson M. B., Horn D., Malik N., Kallestad J, Ochs V., Zarling J. L., Shoyab M. Identification and characterization of cellular receptors for the growth regulator, oncostatin M. J. Biol. Chem. 1989; 264: 4282–4289
   PubMed Web of Science ®Google Scholar
• Liotta L. A. Gene products which play a role in cancer invasion and metastasis. Breast. Cancer Res. Treat. 1988; 11: 113–124
   Google Scholar
• Massague J. The TGF-β family of growth and differentiation factors. Cell 1987; 49: 437–438
   PubMed Web of Science ®Google Scholar
• Malik N., Kallestad J, Gunderson N. L., Austin S. D., Neubauer M. G., Ochs V., Marquardt H., Zarling J. M., Shoyab M., Wei C., Linsley P. S., Rose T. M. Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M. Mol. Cell. Biol. 1989; 9: 2847–2853
   PubMed Web of Science ®Google Scholar
• Morgan D. A., Ruscetti F. W., Gallo R. Selective in vitro growth of T-!ymphocytes from normal human bone marrows. Science 1976; 193: 1007–1008
   PubMed Web of Science ®Google Scholar
• Onozaki K., Matsushima K., Aggarwal B. B., Oppenheim J. J. Human interleukin-1 is a cytocidal factor for several tumor cell lines. J. Immunol. 1985; 135: 3962–3968
   PubMed Web of Science ®Google Scholar
• Pfizenmaier K., Bartsch H., Scheurich P., Seliger B., Ucer U., Vehmeyer K., Nagel G. A. Differential y-interferon response of human colon carcinoma cells: inhibition of proliferation and modulation of immunogenicity as independent effects of y-interferon on tumor cell growth. Cancer Res. 1985; 45: 3503–3509
   PubMed Web of Science ®Google Scholar
• Rennick D., Yang G., Muller-Sieburg C., Smith C., Arai N., Takabe Y., Gemmell L. Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells. Proc. Natl. Acad. Sci. USA 1987; 84: 6889–6893
   PubMed Web of Science ®Google Scholar
• Rubin B. Y., Anderson S. L., Sullivan S. A., Williamson B. D., Carswell E. A., Old L. J. Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor. J. Exp. Med. 1986; 164: 1350–1355
   PubMed Web of Science ®Google Scholar
• Ruoslahti E., Pierschbacher M. D. New perspectives in cell adhesion: RGD and integrins. Science 1987; 238: 491–497
   PubMed Web of Science ®Google Scholar
• Saneto R. P., Airman A., Knobler R. L., Johnson H. M., De Vellis J. Interleukin 2 mediates the inhibition of oligodendrocye progenitor cell proliferation in. vitro. Proc. Natl. Acad. Sci. USA 1986; 83: 9221–9225
   PubMed Web of Science ®Google Scholar
• Schweiger L., Neufeld G., Gospodarowicz D. Basic fibroblast growth factor as a growth inhibitor for cultured human tumor cells. J. Clin. Invest. 1987; 80: 1516–1520
   PubMed Web of Science ®Google Scholar
• Shaw G., Kamen R. A conserved AU sequence from the 3′-untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 1986; 46: 659–667
   PubMed Web of Science ®Google Scholar
• Sugarman B. J., Aggarwal B. B., Hass P. E., Figari I. S., Palladino M. A., Jr., Shepard H. M. Recombinant human tumor necrosis factor-a: effects on proliferation of normal and transformed cells. in vitro. Science 1985; 230: 943–945
   PubMed Web of Science ®Google Scholar
• Sugarman B. J., Lewis G. D., Eessalu T. E., Aggarwal B. B., Shephard H. M. Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Cancer Res. 1987; 47: 780–786
   PubMed Web of Science ®Google Scholar
• Tosato G., Seamon K. B., Goldman N. D., Sehgal P. B., May L. T., Washington G, Jones K. D., Pike S. D. Monocyte-derived human B-cell growth factor identified as interferon-β; BSF-2. Science 1988; 239: 11–6
   Web of Science ®Google Scholar
• Tsai S.-C.J., Gaffney E. V. Modulation of cell proliferation by human recombinant interleukin-1 and immune interferon. J. Natl. Cancer Inst. 1987; 79: 77–81
   PubMed Web of Science ®Google Scholar
• Tsujimoto M., Yip Y. K., Vilcek J. Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. Proc. Natl. Acad. Sci. USA 1985; 82: 7627–7630
   Web of Science ®Google Scholar
• Tucker R. F., Shipley G. D., Moses H. L., HoUey R. W. Growth inhibitor from BSC-1 cells closely related to platelet type β transforming growth factor. Science 1984; 226: 705–707
   PubMed Web of Science ®Google Scholar